Kathleen Squires

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

M A Fischl, M D Hughes, S. Hammer, 1997, The New England journal of medicine.

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

Jialing Huang, Feng-xiang Wang, E. Argyris, 2007, Nature Medicine.

Constant Mean Viral Copy Number per Infected Cell in Tissues Regardless of High, Low, or Undetectable Plasma HIV RNA

Martin A. Nowak, Cynthia A. Derdeyn, Michael S. Saag, 1999, The Journal of experimental medicine.

Phase I Dose‐Escalation Pharmacokinetics of AZT‐P‐ddI (IVX‐E‐59) in Patients with Human Immunodeficiency Virus

K. Squires, J. Sommadossi, L. Agrofoglio, 1997, Journal of clinical pharmacology.

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.

M. Lederman, C. Yiannoutsos, K. Marder, 1999, AIDS.

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

M. Saag, R. Hockett, K. Squires, 1999, The Journal of clinical investigation.

Fluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS

L. Laine, K. Squires, F. Sattler, 1992, Annals of Internal Medicine.

A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.

M. Hirsch, B. Hirschel, S. Staszewski, 1999, The Journal of infectious diseases.

HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians.

David A. Fleming, D. Kuritzkes, M. Saag, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.